Who is sponsoring NCT03821831?

NCT03821831 is sponsored by University of Alberta.

What drugs are being tested in NCT03821831?

Interventions in NCT03821831: Continuous Positive Airway Pressure, Orthodontic intervention.

What condition does NCT03821831 study?

NCT03821831 studies Pediatric Obstructive Sleep Apnea, Pediatric Obesity.

Is NCT03821831 still recruiting?

NCT03821831 is currently terminated. Last updated 29 January 2024.

Last reviewed 2024-01-29 · How we verify

NCT03821831

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treating Children With Obstructive Sleep Apnea After Surgery Failure

Terminated Last updated 29 January 2024

What this trial tests

trial testing Continuous Positive Airway Pressure in Pediatric Obstructive Sleep Apnea in 8 participants. Terminated before completion.

Timeline

3 December 2021

Primary endpoint
8 May 2023

8 May 2023

Quick facts

Lead sponsor	University of Alberta
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	8
Start date	3 December 2021
Primary completion	8 May 2023
Estimated completion	8 May 2023
Sites	1 location across Canada

Drugs / interventions tested

Continuous Positive Airway Pressure
Orthodontic intervention

Conditions studied

Pediatric Obstructive Sleep Apnea — all drugs for Pediatric Obstructive Sleep Apnea →
Pediatric Obesity — all drugs for Pediatric Obesity →

Sponsor

University of Alberta

Who can join

Adults 6 to 16, any sex, with Pediatric Obstructive Sleep Apnea or Pediatric Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the potential improvement of sleep quality in children who have residual obstructive sleep apnea, using either an orthodontic intervention or continuous positive airway pressure (CPAP), versus no treatment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Orthodontic interventions as a management option for children with residual obstructive sleep apnea: a cohort study protocol.
Fagundes NCF, Perez-Garcia A, Graf D, Flores-Mir C, et al · · 2022 · cited 2× · PMID 35705345 · DOI 10.1136/bmjopen-2022-061651

Verify or expand the search:

Other trials of Continuous Positive Airway Pressure

Trials testing the same drug.

NCT07247318 — The Effects of Different Non-invasive Respiratory Support · NA · not yet recruiting
NCT06795971 — Effects of Face Mask Continuous Positive Airway Pressure Vs. Noninvasive Ventilation Vs. High-flow Nasal Oxygen on Intub · NA · recruiting
NCT06512779 — Developing a Treatment Clustering System for Obstructive Sleep Apnea Using Polysomnographic Physiological Signals · NA · recruiting
NCT06391138 — The Effect of OSA on Pregnancy and Fetal Outcomes · not yet recruiting
NCT06393023 — The Effect of OSA on Severity and Prognosis of Patients With CKD · not yet recruiting

Other recruiting trials for Pediatric Obstructive Sleep Apnea

Currently open trials in the same condition.

NCT06850220 — Observational Study on the Impact of Obstructive Sleep Apnea on Executive Function and Empathy Development in Children · recruiting
NCT05052216 — Development of a Wearable Point of Care Monitoring Device for Pediatric Obstructive Sleep Apnea · recruiting

Other University of Alberta trials

Trials by the same sponsor.

NCT03240900 — Electrical Stimulation for Improving Postoperative Breast Sensation · NA · not yet recruiting
NCT04231760 — The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD · Phase 1, PHASE2 · not yet recruiting
NCT06649604 — Reducing Pain From Retinal Laser With Vibrational Stimulation · NA · not yet recruiting
NCT06824077 — Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle · EARLY_PHASE1 · not yet recruiting
NCT06920914 — Effects of Minimally vs. Ultra-Processed Diets on Potassium (K) Handling in CKD · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03821831 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alberta
Last refreshed: 29 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03821831.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing